Should You Buy AdaptHealth Corp. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, AdaptHealth Corp. (AHCO) carries a solid Quality of Company rating of 6.3/10. Trading at $5.80, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 6 of 7 CirclFi valuation models project upside for AdaptHealth Corp. (AHCO) at $5.80 — the model consensus leans bullish, with a Quality Score of 6.3/10 and Value-Trap risk of 19/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for AdaptHealth Corp. (AHCO) in 2026?
What Is the Bull Case vs the Bear Case for AdaptHealth Corp. (AHCO)?
| Bull case — $32.14 target (+454.1%) | Bear case — $2.07 target (-64.4%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +247.9% across 6 bullish models from the current price of $5.80. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $2.07 (-64.4%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model targets a fair value of $32.14 (+454.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +518.4% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: regulatory pathway clarity could provide meaningful support for AdaptHealth Corp.'s revenue and margin trajectory in the Medical Devices space. | Industry headwind: clinical trial failure represents a meaningful risk for AdaptHealth Corp. and its Medical Devices peers. |
How Does AHCO Compare to Its Medical Devices Peers?
Valuation data pages: PETV · OFIX · APYX · STIM · ECOR · NSPR · ELUT · BWAY · SRTS · IRMD · PODD
Which Other Stocks Score Like AHCO on Quality?
Closest companies to AHCO’s Quality of Company score of 6.3/10, across all industries.
- NTLA — Intellia Therapeutics, Inc. (QOC 6.3) · analysis
- XFOR — X4 Pharmaceuticals, Inc. (QOC 6.3) · analysis
- SMJF — SMJ International Holdings Inc. (QOC 6.3) · analysis
- CVR — Chicago Rivet & Machine Co. (QOC 6.3) · analysis
- AERG — Applied Energetics, Inc. (QOC 6.3) · analysis
- UPLD — Upland Software, Inc. (QOC 6.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does AHCO Appear In?
So Is AdaptHealth Corp. (AHCO) Worth Buying in 2026?
AdaptHealth Corp. at $5.80 presents what our engine identifies as a high-conviction opportunity: 6 of 7 models see upside, quality stands at 6.3/10, and the median fair value of $20.18 implies +247.9% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. AdaptHealth Corp.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About AHCO Stock?
Should I buy AHCO stock right now?
Based on CirclFi's multi-model analysis, 6 of 7 models see upside for AHCO at $5.80. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in AdaptHealth Corp.?
Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (1455% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does AHCO compare to its competitors?
Among Medical Devices peers, AHCO holds a Quality Score of 6.3/10. Comparable companies include PETV (QOC 6.3), OFIX (QOC 6.2), APYX (QOC 6.3). The relative ranking helps investors identify whether AHCO offers better fundamental quality than alternatives in the same sector.
Is AHCO a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. AHCO's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy AHCO at?
CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $2.07 to $32.14. At $5.80, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for AHCO.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad